Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
141.6 DKK | -7.39% | -6.47% | +39.92% |
Jun. 04 | Transcript : ALK-Abelló A/S - Analyst/Investor Day | |
Jun. 03 | ALK Presents Positive Phase 3 Paediatric Trial Data Offering New Hope for Children with Respiratory Allergy | CI |
Sales 2024 * | 5.39B 788M | Sales 2025 * | 6B 877M | Capitalization | 31.32B 4.57B |
---|---|---|---|---|---|
Net income 2024 * | 771M 113M | Net income 2025 * | 1.13B 165M | EV / Sales 2024 * | 5.76 x |
Net cash position 2024 * | 248M 36.26M | Net cash position 2025 * | 1.04B 152M | EV / Sales 2025 * | 5.04 x |
P/E ratio 2024 * |
39.6
x | P/E ratio 2025 * |
27.8
x | Employees | 2,828 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.05% |
Latest transcript on ALK-Abelló A/S
1 day | -7.39% | ||
1 week | -6.47% | ||
Current month | -7.21% | ||
1 month | -4.84% | ||
3 months | +7.19% | ||
6 months | +51.85% | ||
Current year | +39.92% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Halling
CEO | Chief Executive Officer | 47 | Dec. 31 |
Director of Finance/CFO | 52 | 23-05-31 | |
Chief Tech/Sci/R&D Officer | - | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 21-03-17 | |
Anders Hedegaard
CHM | Chairman | 63 | 20-03-10 |
Director/Board Member | 64 | 15-03-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.09% | 7 M€ | -.--% | - | |
0.03% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 141.6 | -7.39% | 1,309,994 |
24-06-03 | 152.9 | +0.20% | 391,832 |
24-05-31 | 152.6 | +1.60% | 427,750 |
24-05-30 | 150.2 | -0.79% | 290,387 |
24-05-29 | 151.4 | -1.11% | 139,962 |
Delayed Quote Nasdaq Copenhagen, June 04, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.92% | 4.57B | |
+42.69% | 750B | |
+34.11% | 606B | |
-6.87% | 356B | |
+18.74% | 326B | |
+6.76% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.64% | 167B |
- Stock Market
- Equities
- ALK B Stock